Cargando…
KSK-74: Dual Histamine H(3) and Sigma-2 Receptor Ligand with Anti-Obesity Potential
Many studies involving compounds that enhance histamine release, such as histamine H(3) receptor (H(3)R) antagonists, have shown efficacy in inhibiting weight gain, but none have passed clinical trials. As part of the search for H(3) receptor ligands that have additional properties, the aim of this...
Autores principales: | Mika, Kamil, Szafarz, Małgorzata, Zadrożna, Monika, Nowak, Barbara, Bednarski, Marek, Szczepańska, Katarzyna, Pociecha, Krzysztof, Kubacka, Monika, Nicosia, Noemi, Juda, Izabela, Kieć-Kononowicz, Katarzyna, Kotańska, Magdalena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266460/ https://www.ncbi.nlm.nih.gov/pubmed/35806019 http://dx.doi.org/10.3390/ijms23137011 |
Ejemplares similares
-
Histamine H(3) Receptor Ligands—KSK-59 and KSK-73—Reduce Body Weight Gain in a Rat Model of Excessive Eating
por: Mika, Kamil, et al.
Publicado: (2021) -
Evaluation of Some Safety Parameters of Dual Histamine H(3) and Sigma-2 Receptor Ligands with Anti-Obesity Potential
por: Mika, Kamil, et al.
Publicado: (2023) -
The GPR18 Agonist PSB-KD-107 Exerts Endothelium-Dependent Vasorelaxant Effects
por: Kotańska, Magdalena, et al.
Publicado: (2021) -
Effects of GPR18 Ligands on Body Weight and Metabolic Parameters in a Female Rat Model of Excessive Eating
por: Kotańska, Magdalena, et al.
Publicado: (2021) -
The histamine H(3) receptor inverse agonist pitolisant reduces body weight in obese mice
por: Kotańska, Magdalena, et al.
Publicado: (2018)